The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
This company have again failed to deliver guidance. What happened to... "Management now guide full year ImmunoINSIGHTS revenues to be not less than GBP6.0M.", let alone EarlyCDT revenue. Group revenue was £3.86m. I'm reading any future revenue(only says "potential" anyway) statement today with a pinch of salt.
CFO selling P!ssed me off, as did them not getting the £2m payment for sales.
Last straw today for me with cash in bank dwindling, so sold at a very large loss(most the trades were mine first thing, totalling 176,732). Was already 50% cash, now increased a bit, but as someone said yesterday, at least you can get a return on cash in the bank these days, as opposed to having it invested her
Good luck all, this is just not for me this business as never truly understood it. Stick to what I know best. Can't win them all.
Tragic....that's all I can say
The CEO submitted a change of registered address - to a rather nice looking tudor lodge - for another of his companies in Aug 2021. Assume they don't come cheap ...
What a complete waste of the last 4 and half years of my life. Who really cares what this does it’s 50 odd pence end of
The clue was the CFO selling! Adds up now.
It’s such a shame as the market doesn’t attribute value for IP, contracts or its unreplicable assets. But ONC is not alone. I follow around 50 companies in this sector (similar in others) and it’s been hammered!
In the max chart it may dip below 50p but I have added at sub 60p.
38m mcap is insane even if there’s a placing. Low mcap relative to assets, distressed sp and quality is what makes this a prime takeover target now. But one shouldn’t buy on takeover hopes that may never happen!
Still let’s see what happens.
Usual caveats
Trek
As per the results, the revenue in 2021 and 2022 are similar i.e. 3,859 in 2022 and 3,722 in 2021. However the cost of sales has increased around 3 times in 2022. That is 2,402 in 2022 and 865 in 2021. I would have expected that the cost would have gone down or similar considering that they have already been an established player in the market. Can someone please provide some insight how to understand those figures?
I sold this at £1.80 a while a go but kept it on my watch. Not a lot of shares are worth keeping long term on AIM. Cash burn is insane. Making very little but spending huge. NHS contract is why i kept this in my watch list but i very much doubt its coming. or will take years. They'll have to get money from somewhere and you know what follows. Sell when in profit and run is the policy. Never listen to rampers. I have only held SCE a terrific company, and trade the rest.
Ops wise and signing contracts with tier 1 pharma this is awesome!
9.9m loss even after the extended period has spooked the market. It’s obvious that the market is expecting some sort of funding to plug that gap. I have to look back through and see if the run rate can sustain it.
I think we may see director buys after close period and wouldn’t be surprised if later on we get picked up. Either that or it’s going to be a loan or equity.
Just seems such an overreaction. An award winning great British biotech with deals across top 15 Pharma’s and nhs!
I will be picking some more up once it settles as fortunately having done well elsewhere I can average down and wait it out.
Usual caveats
Trek
Might aswell stick the money in a current account do better than this
They have me standing against a wall with my pants down. I have nothing left to give and everything to lose here....come on Oncimmune! Show me why I thought it was a good idea to put my money where your mouth is.
Nails curling here too. I am baffled. No-one seems to be able to explain a sudden 6 % drop when no apparent news is floating about. we are ahead of earnings report. Usually this indicates that some investors have cold feet.
It’s half of what I bought it for 4 and half years ago.
Superb company fair play
Ok I am just going to take the most intuitive approach and say it will be the 12 month period from September 2021 to August 2022
*YoY revenue
You are right....whilst I want to stay optimistic, I have a weird feeling that it could drop to 0.55gbp even if you revenue doubled.....
We will see....that's all we can do.
Does it really matter? Not like it’s going to move anyway
'The Company recently changed its financial year-end to August from May with these interim results therefore covering a 12-month period. The Company now expects to announce its interim results no later than 30 September 2022.'
When results are published, will they account for the 6 month period from
1. Dec 21 - May 22 (6 m) not because not 12 m
2. Dec 21 - Aug 22 (9 m) not because not 12 m
3. Sep 21 - Aug 22 (12 m)
4. Jun 21 - May 22 (12 m)
Has anyone got a clue?
If/when there is a sudden move north, I intend to be fully invested here, as I am now. I was in GLO when it did the same, and it felt great. And not too long to the end of September now.
Let it drop further and you get a great buying opportunity.
You don't just revamp Website, appoint new member to board, adjust you fiscal calendar etc for no reason. These guys are getting ready for the major league.
Share price is crap right now, I am frustrated, I have too much in here and I am also wondering whether I shoulda coulda woulda....
But you know what....I sure as he'll am not going to miss out when this stock breaks through. Literally all news, reports, publications hint at this being a diamond in the rough.....
I won't make the worst investment decision of my life by selling now. I can feel it in my urine.... this one is about to pop.
It has to!
Back to 75p this week then
My average now is 104, on paper at least! Looking to add back in later in if 70’s come again and then take them out if it goes back up. Just trying to work average down! Will still keep core for when good times return!
Wouldn’t be surprised to see directors buy at these levels after close period.
Usual caveats
Trek
Your right and I agree with you. Suppose the great grand kids will benefit from this anyway
I d stick to buying shell
And Bp
Not sure why you
Guys are playing this. Bed wetting over something that is
Very common re results in peak
Holiday season. Things always get slightly delayed
My money is on
Aliststair ex Syneos boss and Adam delivering
Pathetic seriously. Like you said year 5 and like you I’m still in on these. Only benefit was my 35p buy about 8 decades ago. Who gives a ****e about a new website I just want it to go up so I can continue with my life. Boring ****e